CHMP backs bluebird bio’s gene therapy for rare disease ALDUS biotech bluebird bio has had a challenging time in the last few months, so a recommendation for Share XCHMP backs bluebird bio’s gene therapy for rare disease ALDhttps://pharmaphorum.com/news/chmp-backs-bluebird-bios-gene-therapy-for-rare-disease-ald/
